Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Immunisation: A Two-part Study Investigating Antigen Specific B Cell Receptors
NCT01821547Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Mar 2013
- Primary completion
- Apr 2014
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by University of Oxford. Started Mar 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01821547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821547.